Video Education to Improve Blood Pressure Control in Patients With Ischemic Heart Disease and Hypertension (V-EDUCATE)

NCT07210073 | Completed

• 1 other identifier: 2024-02-053
• Study Type: interventional
• Target: 218
• Locations: 1 country
• Sites: 1

Brief Summary

We investigated whether video-based education using deepfake technology could improve blood pressure measurement adherence and medication adherence in patients with ischemic heart disease accompanied by hypertension.

Conditions

Hypertension (HTN); Ischemic Heart Disease

Outcome Measures

Primary Outcomes (2)

• Adherence to Home Blood Pressure Monitoring (HBPM)

  Proportion of days during the 30-day follow-up period in which participants recorded four BP measurements per day (two in the morning, two in the evening) using a validated home BP device (InBody BP170).

  4 weeks

• Medication Adherence Assessed by Pill Count

  Proportion of prescribed antihypertensive medication doses taken during the 30-day follow-up period, assessed by pill counts at the follow-up visit.

  4 weeks

Secondary Outcomes (6)

• Change in Office Systolic Blood Pressure From Baseline to 4 Weeks

  4 weeks

• Change in Office Diastolic Blood Pressure From Baseline to 4 Weeks

  4 weeks

• Difference in Mean Systolic Blood Pressure Between Home BP Monitoring and 24-Hour Ambulatory Monitoring

  4 weeks

• Difference in Mean Diastolic Blood Pressure Between Home BP Monitoring and 24-Hour Ambulatory Monitoring

  4 weeks

• Number of Antihypertensive Medications Prescribed Per Participant

  4 weeks

Study Arms (2)

Video education

EXPERIMENTAL

Participants receive personalized video-based education developed using deepfake technology to replicate the patient's primary physician's voice, in addition to usual care.

Behavioral: Video Education

Standard Care

ACTIVE COMPARATOR

Participants receive standard treatment for ischemic heart disease and hypertension, without additional video-based education.

Other: Control

Interventions

Video Education BEHAVIORAL

Videos were created using deepfake technology, utilizing AI to replicate the voice of the patients' primary physician.

Video education

Control OTHER

Standard treatment

Standard Care

Eligibility Criteria

• Age: 19 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adults aged 19 years or older, both male and female, with a history of hypertension or who have taken antihypertensive medication at least once, satisfying one or more of the following ischemic heart disease conditions (PCI, CABG, CAD \>50% by CCT or CAG), or patients with a history of hypertension or currently taking antihypertensive medication.
• Individuals who have voluntarily provided written consent to participate in this clinical trial.

You may not qualify if:

• SBP \< 90 mmHg or DBP \< 50 mmHg
• Individuals intolerant to all antihypertensive medications
• Patients with heart failure due to other causes, Pregnant women, those suspected of being pregnant, or those who are breastfeeding
• Patients whom the investigator deems legally or mentally unfit to participate in the clinical trial
• Patients who have participated in another clinical study involving investigational drugs within 4 weeks prior to screening.

Sponsors & Collaborators

• Keimyung University Dongsan Medical Center: lead

Study Sites (1)

Keimyung University Dongsan Hospital

Daegu, Daegu, 42601, South Korea

Location

MeSH Terms

Conditions

Hypertension; Myocardial Ischemia

Condition Hierarchy (Ancestors)

Vascular Diseases; Cardiovascular Diseases; Heart Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 14, 2025
• First Posted: October 7, 2025
• Study Start: May 27, 2024
• Primary Completion: February 4, 2025
• Study Completion: March 30, 2025
• Last Updated: October 7, 2025

Record last verified: 2025-02

Data Sharing

• IPD Sharing: Will not share

Locations

KR (1)